Navigation Links
EQUICARE CS Cancer Survivorship Case Management Software Listed as a "Best Practices" Resource by the American College of Surgeons Commission on Cancer (COC)
Date:5/29/2012

PALO ALTO, Calif., May 29, 2012 /PRNewswire/ -- EQUICARE CS, a cancer survivorship case management software program jointly offered by Varian Medical Systems (NYSE: VAR) and Equicare Health, Inc., has been included by the American College of Surgeons Commission on Cancer (CoC) in its "Best Practices Repository." The repository is a list of resources designed to help cancer treatment centers in the U.S. adopt rigorous standards for high-quality patient-centered care, in order to qualify to become CoC-accredited cancer programs.

There are over 13 million cancer patients currently living in the U.S., and the number is expected to grow to 18 million by 2020. Only a very small number of cancer treatment centers are set up to deliver survivorship care once treatment is over. Nevertheless, after treatment for cancer, many patients require post-treatment follow-up care for late effects of treatment, secondary cancers, and quality of life issues. Some need further diagnostic testing, or nutritional and counseling services. 

"Cancer survivors benefit most when they have access to coordinated post-treatment care," said Malcolm Wright, vice president of product management at Equicare Health. "Therefore, the CoC has mandated that all organizations seeking their accreditation will have to create a formal plan for delivering survivorship care by 2014, and they will have to implement that plan by 2015. EQUICARE CS can help them comply with these requirements."

According to the American College of Surgeons, CoC accreditation is a voluntary commitment by a cancer program that ensures patients will have access to a full scope of services required to diagnose, treat, rehabilitate, and support patients with cancer and their families. By 2015, all CoC-accredited institutions will have to produce survivorship care plans for each of their patients, including a record of care received, important disease characteristics, and a follow-up care plan incorporating recognized evidence-based standards of care, when available.

The EQUICARE CS case management system was specifically designed to help clinics provide cancer survivors with a personalized plan for follow-up care. It is a web-based, patient-centric tool that is designed to help cancer survivors, their caregivers, and their healthcare providers achieve better clinical compliance, which can result in improved patient outcomes following treatment for cancer.

"The EQUICARE CS system guides clinicians in generating a care plan based on best practices and established guidelines," said Chris Toth, vice president of marketing for Varian Medical Systems. "It offers patients round-the-clock access to their care plans through a personalized portal on the Internet. We are very gratified that the American College of Surgeons has recognized the value of this system, which was designed to help cancer centers implement robust, world-class survivorship care programs."

Online resources:

American College of Surgeons Cancer Programs:
http://www.facs.org/cancer/

COC Best Practices Repository:
https://www.socialtext.net/cancer_standards/coc_best_practices_repository 
(for Survivorship materials, click on "Proprietary Material")

ABOUT VARIAN MEDICAL SYSTEMS
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. Varian Medical Systems employs approximately 6,000 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.

FOR INFORMATION CONTACT:   
Meryl Ginsberg, 650.424.6444
meryl.ginsberg@varian.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... LOVELAND, Colo. , July 26, 2017 ... Tristan Guttridge and the Bimini SharkLab to custom design the ... diagnostic images of sharks in their native habitat. In ... for Discovery Channel,s Shark Week, Dr. Guttridge approached ... to take pregnancy diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... August 17, 2017 , ... Tanya Atagi, MD, is excited to announce ... Atagi Plastic Surgery and Skin Aesthetics. , To tighten skin on the face, ... ultrasound energy. Smoother, younger-looking skin is revealed on all other areas of the body ...
(Date:8/17/2017)... CO (PRWEB) , ... August 17, 2017 , ... ... Moral Injury: The Journey to Healing Through Forgiveness ($15.99, paperback, 9781498497626; $7.99, ... (war) trauma, to encourage inner healing of memories and achieve forgiveness, through a ...
(Date:8/17/2017)... , ... August 17, 2017 , ... Pot Valet is ... service growing to every city in the state, and soon, every state in the ... their need to visit a cannabis dispensary altogether. , According to Pot ...
(Date:8/17/2017)... , ... August 17, 2017 , ... Centrifugation is more ... in the laboratory that we can no longer do without. And just like a ... of your device. , In this webinar, attendees will learn about the most important ...
(Date:8/17/2017)... Seattle, WA and Lighthouse Point, FL (PRWEB) , ... ... ... Seattle-based healthcare technology firm and Cancer Center Business Development Group, a Florida-based oncology ... that examined patient care data to quantify the dollar amount of attributable savings ...
Breaking Medicine News(10 mins):